Used in research settings to investigate immune checkpoint pathways, particularly targeting the LAG-3 receptor. Shows potential in enhancing T-cell activation, making it a candidate for cancer immunotherapy development. Studied for its ability to modulate immune responses in tumor microenvironments. Currently limited to preclinical studies, with no approved therapeutic uses as of now.